BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36171505)

  • 1. Anatomical distribution of cancer stem cells between enhancing nodule and FLAIR hyperintensity in supratentorial glioblastoma: time to recalibrate the surgical target?
    Altieri R; Broggi G; Certo F; Pacella D; Cammarata G; Maione M; Garozzo M; Barbagallo D; Purrello M; Caltabiano R; Magro G; Barbagallo G
    Neurosurg Rev; 2022 Dec; 45(6):3709-3716. PubMed ID: 36171505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FLAIRectomy in Supramarginal Resection of Glioblastoma Correlates With Clinical Outcome and Survival Analysis: A Prospective, Single Institution, Case Series.
    Certo F; Altieri R; Maione M; Schonauer C; Sortino G; Fiumanò G; Tirrò E; Massimino M; Broggi G; Vigneri P; Magro G; Visocchi M; Barbagallo GMV
    Oper Neurosurg (Hagerstown); 2021 Jan; 20(2):151-163. PubMed ID: 33035343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.
    Neira JA; Ung TH; Sims JS; Malone HR; Chow DS; Samanamud JL; Zanazzi GJ; Guo X; Bowden SG; Zhao B; Sheth SA; McKhann GM; Sisti MB; Canoll P; D'Amico RS; Bruce JN
    J Neurosurg; 2017 Jul; 127(1):111-122. PubMed ID: 27715437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
    Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G
    J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional characterization of Glioblastoma cancer stem cells identified through 5-aminolevulinic acid-assisted surgery [corrected].
    Rampazzo E; Della Puppa A; Frasson C; Battilana G; Bianco S; Scienza R; Basso G; Persano L
    J Neurooncol; 2014 Feb; 116(3):505-13. PubMed ID: 24401960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
    Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
    Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery.
    Roessler K; Becherer A; Donat M; Cejna M; Zachenhofer I
    Neurol Res; 2012 Apr; 34(3):314-7. PubMed ID: 22449387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.
    Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL
    Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
    Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
    Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic Definition of Enhancing Core and FLAIR Hyperintensity Region of Glioblastoma, IDH-Wild Type: A Clinico-Pathologic Study on a Single-Institution Series.
    Broggi G; Altieri R; Barresi V; Certo F; Barbagallo GMV; Zanelli M; Palicelli A; Magro G; Caltabiano R
    Brain Sci; 2023 Jan; 13(2):. PubMed ID: 36831791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of resection of peritumoral diffusion tensor imaging-detected abnormality as a predictor of survival in adult glioblastoma patients.
    Yan JL; van der Hoorn A; Larkin TJ; Boonzaier NR; Matys T; Price SJ
    J Neurosurg; 2017 Jan; 126(1):234-241. PubMed ID: 27058207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscope-assisted fluorescence-guided resection allowing supratotal removal in glioblastoma surgery.
    Bettag C; Schregel K; Langer P; Thomas C; Behme D; Stadelmann C; Rohde V; Mielke D
    Neurosurg Focus; 2021 Jan; 50(1):E3. PubMed ID: 33386004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological Insights on Imaging Results of Intraoperative Magnetic Resonance Imaging, 5-Aminolevulinic Acid, and Intraoperative Ultrasound in Glioblastoma Surgery.
    Coburger J; Scheuerle A; Pala A; Thal D; Wirtz CR; König R
    Neurosurgery; 2017 Jul; 81(1):165-174. PubMed ID: 28204539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
    Coburger J; Hagel V; Wirtz CR; König R
    PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery.
    Cordova JS; Gurbani SS; Holder CA; Olson JJ; Schreibmann E; Shi R; Guo Y; Shu HK; Shim H; Hadjipanayis CG
    Mol Imaging Biol; 2016 Jun; 18(3):454-62. PubMed ID: 26463215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is fluorescence-guided surgery with 5-ala in eloquent areas for malignant gliomas a reasonable and useful technique?
    Picart T; Armoiry X; Berthiller J; Dumot C; Pelissou-Guyotat I; Signorelli F; Guyotat J
    Neurochirurgie; 2017 Jun; 63(3):189-196. PubMed ID: 28522184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelioid glioblastoma changed to typical glioblastoma: the methylation status of MGMT promoter and 5-ALA fluorescence.
    Tanaka S; Nakada M; Hayashi Y; Nakada S; Sawada-Kitamura S; Furuyama N; Suzuki T; Kamide T; Hayashi Y; Yano S; Hamada J
    Brain Tumor Pathol; 2011 Feb; 28(1):59-64. PubMed ID: 21188541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectral Radiance of Protoporphyrin IX Fluorescence and Its Histopathological Implications in 5-Aminolevulinic Acid-Guided Surgery for Glioblastoma.
    Yoneda T; Nonoguchi N; Ikeda N; Yagi R; Kawabata S; Furuse M; Hirose Y; Kuwabara H; Tamura Y; Kajimoto Y; Kuroiwa T
    Photomed Laser Surg; 2018 May; 36(5):266-272. PubMed ID: 29480754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.